000 | 01591 a2200433 4500 | ||
---|---|---|---|
005 | 20250513054037.0 | ||
264 | 0 | _c19950113 | |
008 | 199501s 0 0 eng d | ||
022 | _a0022-1899 | ||
024 | 7 |
_a10.1093/infdis/170.6.1613 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHol, C | |
245 | 0 | 0 |
_aExperimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. _h[electronic resource] |
260 |
_bThe Journal of infectious diseases _cDec 1994 |
||
300 |
_a1613-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmoxicillin _xtherapeutic use |
650 | 0 | 4 | _aAmoxicillin-Potassium Clavulanate Combination |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aClavulanic Acids _xtherapeutic use |
650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aMoraxella catarrhalis _xenzymology |
650 | 0 | 4 |
_aNeisseriaceae Infections _xcomplications |
650 | 0 | 4 | _aOrgan Specificity |
650 | 0 | 4 | _aPenicillin Resistance |
650 | 0 | 4 |
_aPenicillins _xtherapeutic use |
650 | 0 | 4 |
_aPneumonia, Pneumococcal _xcomplications |
650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
650 | 0 | 4 |
_abeta-Lactamases _xmetabolism |
700 | 1 | _aVan Dijke, E E | |
700 | 1 | _aVerduin, C M | |
700 | 1 | _aVerhoef, J | |
700 | 1 | _avan Dijk, H | |
773 | 0 |
_tThe Journal of infectious diseases _gvol. 170 _gno. 6 _gp. 1613-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/170.6.1613 _zAvailable from publisher's website |
999 |
_c7995336 _d7995336 |